(Q43520265)

24 November 2017

Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha (English)

1 reference

24 November 2017

0 references

Konrad T

1

1 reference

24 November 2017

Zeuzem S

2

1 reference

24 November 2017

Vicini P

3

1 reference

24 November 2017

Toffolo G

4

1 reference

24 November 2017

Briem D

5

1 reference

24 November 2017

Lormann J

6

1 reference

24 November 2017

Herrmann G

7

1 reference

24 November 2017

Berger A

8

1 reference

24 November 2017

Kusterer K

9

1 reference

24 November 2017

Teuber G

10

1 reference

24 November 2017

Cobelli C

11

1 reference

24 November 2017

Usadel KH

12

1 reference

24 November 2017

1 February 2000

1 reference

European Journal of Clinical Investigation

24 November 2017

1 reference

24 November 2017

30

1 reference

24 November 2017

111-121

1 reference

24 November 2017

2

1 reference

High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.

24 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

High prevalence of hepatitis C virus infection in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Effect of interferon on glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Effects of interferon alpha on insulin binding and glucose transport in human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Interferon therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Impaired carbohydrate metabolism during a mild viral illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Blood lipids of patients with chronic hepatitis: differences related to viral etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Disordered Energy and Protein Metabolism in Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Impaired early insulin response to intravenous glucose in alcoholic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

Antidiabetic effects of interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00608.X

10.1046/J.1365-2362.2000.00608.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference